Harnessing the Immune System to fight cancer


Takis main focus is the development of therapeutic cancer vaccines against tumor antigens which play a role in tumor development and maintenance.

To explore Takis opportunities, click here

Application deadline: 20.11.2019
 

Start date: 01.03.2020
(or 01.04.2020)


Requirements:
<4 years after MSc, no PhD title,
<12 months in the hosting country in the last 3 years

Our team
is recognized

for the conception and implementation of a number of innovative technologies with the goal to improve in vivo gene transfer, regulation of gene expression and immunogenicity.

 

Takis as a CRO provides a variety of research services
 

in the areas of Oncology, Immunology, Infectious Diseases and novel preclinical models.

 
 

eit HEALT - European Union

eit Health
Takis Biotech

Harnessing the Immune System to fight cancer.

 
 
 
Takis S.r.l.

Via Castel Romano, 100
00128 Rome - Italy
P. I.V.A. 10700711004

 
 
Follow us